Clarus Ventures II, LLC
CIK 1431437 · last filed 2018-01-03
Clarus Ventures II, LLC is a corporate insider who has filed 3 SEC Form 4 insider transactions across 1 company since 2015. The most recent filing, for NSTG, was dated Jan 3, 2018. The firm reports its address in Cambridge, MA. 43 SEC filings were submitted jointly with Clarus Lifesciences II, L.P.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
3
$0
Filer Profile
SUITE 1210
CAMBRIDGE, MA 02142
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NanoString Technologies Inc (NSTG) Delisted | 10%+ Owner | — | $0.11 | — | $0 | 3 | 2018-01-03 |
Recent Filings
3 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-01-03 | NanoString Technologies Inc (NSTG) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-01-05 | NanoString Technologies Inc (NSTG) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-01-05 | NanoString Technologies Inc (NSTG) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.